Bluepha is a biomanufacturing company that produces Bluepha® PHA, a fully biodegradable material derived from microbial fermentation of oils and starches. This technology provides a sustainable alternative to conventional plastics, addressing the environmental impact of plastic waste by offering certified, compostable solutions for various applications, including packaging and food contact materials.

Calterah designs and develops CMOS single-chip millimeter-wave radar sensors for precise object detection and tracking in various applications. These sensors enhance situational awareness and improve safety in environments where traditional sensing technologies may fail.

Covariant develops the Covariant Brain, an AI robotics platform designed to automate warehouse operations. This platform utilizes a multimodal robotics dataset to enable robots to pick diverse SKUs with high autonomy from day one. The system leverages fleet learning to adapt to changing business needs and scale fulfillment capabilities.

Kolmostar develops ultra-low power GNSS positioning solutions that utilize advanced statistical signal processing and high-dimensional space search theory to achieve highly accurate outdoor positioning in urban environments. Their technology addresses high energy consumption and positioning drift issues common in traditional GNSS systems, reducing energy use by 100 times while maintaining precise location data for IoT devices.

Develops photonic computing solutions that integrate optical and electronic components to accelerate AI workloads, addressing the limitations of traditional electronic systems, such as the "memory wall." Products like the HUMMINGBIRD optical network-on-chip and PACE photonic arithmetic engine enable exponential increases in processing speed and efficiency for domain-specific applications.

METiS Pharmaceuticals utilizes AI, machine learning, and quantum simulation to enhance drug delivery and discovery, developing a diverse pipeline of over 10 drugs across various therapeutic areas. The company aims to create optimal therapies for unmet medical needs by leveraging high-throughput experimentation and proprietary technology platforms like AiLNP, AiRNA, and AiTEM.

Naxions is a healthcare company that utilizes AI-driven semantic understanding and deep learning algorithms to provide end-to-end pharmaceutical promotion services, enhancing compliance and efficiency for drug companies. By connecting over 300,000 grassroots doctors with more than 100 pharmaceutical products, Naxions enables rapid market coverage and significant business growth for its clients.

NeuralGalaxy is focused on developing neurobiological therapies to treat brain disorders such as Alzheimer's and Parkinson's disease. The company utilizes advanced neuroimaging and biomarker analysis to identify and target specific neural pathways affected by these conditions, improving patient outcomes through precision medicine.

NextVPU designs and manufactures embedded AI visual processing chips, such as the NE-D163A, which enable high-resolution depth data capture and processing for smart devices without the need for external processors. Their technology addresses the challenges of low accuracy and high latency in depth perception for applications in security, robotics, and consumer electronics.

OnQuality Pharmaceuticals develops targeted supportive care treatments that mitigate the side effects of specific cancer therapies, enabling patients to maintain their treatment regimens. By addressing dose-limiting toxicities, the company enhances the quality of life for cancer patients undergoing anti-cancer therapy.

Singleron provides an integrated platform that combines tissue preservation, automated 8‑channel dissociation, and high‑throughput single‑cell processing with a suite of library preparation kits for scRNA‑seq, V(D)J, and other multi‑omics assays. The system includes the Matrix NEO™ and Tensor instruments for up to 30 000 cells per run and cloud‑based analysis tools (CeleLens™ and SynEcoSys®) that deliver code‑free QC, annotation, and visualization. Optional contract services enable end‑to‑end sample handling, sequencing, and bioinformatics for academic, biotech, and pharma projects.

SoundAI develops acoustic technology that utilizes artificial intelligence to enhance human-computer interaction through sound recognition and processing. The company addresses challenges in user engagement and accessibility by providing precise audio feedback and context-aware responses in various applications.

Sunyur offers digital procurement solutions that streamline the purchasing process through automated workflows and data analytics. The platform reduces procurement costs and enhances supplier management, enabling businesses to optimize their purchasing decisions and improve operational efficiency.

This platform connects users with on-demand transportation services through a mobile application. It facilitates personal rides, scheduled trips, and food delivery via Uber Eats. The service also provides logistics solutions for businesses and opportunities for individuals to earn income as drivers or delivery persons.

Xellsmart develops clinical-grade induced pluripotent stem cell (iPSC) therapies specifically targeting neurodegenerative diseases, such as Parkinson's disease, for which there are currently no effective treatments. Their approach focuses on providing scalable and cost-effective stem cell solutions to improve patient outcomes in these critical areas of healthcare.

XtalPi is a pharmaceutical technology company that utilizes computational modeling and machine learning to predict drug interactions and properties, followed by experimental validation in wet labs. This approach reduces the time and cost associated with traditional drug discovery processes, enabling faster development of effective therapeutics.

Develops general-purpose footed robots designed for versatile mobility and task execution in diverse environments. These robots address challenges in automation and physical interaction by combining advanced locomotion systems with adaptable control algorithms, enabling applications in industries such as logistics, agriculture, and service.

The company provides the ROPA orthopedic intelligent surgical robot, an AI‑driven platform that generates patient‑specific joint replacement plans from pre‑operative imaging and executes bone resections with sub‑millimeter accuracy using a six‑degree‑of‑freedom robotic arm and real‑time optical navigation. Integrated force/torque sensors and haptic feedback reduce operative time while preserving surgeon control, and all intra‑operative data are logged to a cloud analytics service for outcome tracking and model refinement. The system supports standard DICOM and HL7 interfaces and is backed by a dedicated clinical training center for orthopedic surgeons and hospital departments.